Leukemia

In 2018, at the height of the chimeric antigen receptor T-cell therapy revolution and in the heart of its implementation, Healio’s Cell Therapy Next staff went onsite to University of Pennsylvania’s newly minted center.

Patients with chronic lymphocytic leukemia who achieved undetectable minimal residual disease achieved significantly longer PFS than patients with minimal residual disease, according to results of a systematic review and meta-analysis.

Enrollment for a randomized phase 2 trial designed to compare a triplet regimen and doublet regimen for certain patients with leukemia has been discontinued due to low likelihood of benefit.

Fixed-duration acalabrutinib plus venetoclax, with or without obinutuzumab, improved survival compared with standard chemoimmunotherapy for certain adults with leukemia, according to a topline data announcement.

Use of blinatumomab with consolidation chemotherapy significantly extended OS for adults with minimal residual disease-negative B-cell precursor acute lymphoblastic leukemia, according to randomized phase 3 study results.

Patients with acne who used benzoyl peroxide products did not have a risk for malignancy or increased blood benzene levels, according to a pair of studies published in the Journal of the American Academy of Dermatology.

In this video, Eric Winer, MD, discusses the results of research into acute myeloid leukemia presented at ASCO Annual Meeting.

In this video, Eric Winer, MD, discusses the results of the TakeAim study into acute myeloid leukemia, which he helped present at ASCO Annual Meeting.

Jae Park, MD, compared the moment to a baby being born.

In this video, Andrew Hantel, MD, discusses the results of a study he helped present at ASCO Annual Meeting on racial disparities in acute myeloid leukemia trials.